Clinical Trial Update: A 12-week Human Trial to Compare the Efficacy and Safety of Polycan on Bone Metabolism [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating Polycan for bone metabolism in perimenopausal women has completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis

Drugs mentioned

• Polycan

Snippet

Sponsor: Chonbuk National University Hospital | Conditions: Bone Health in Perimenopausal Women | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-10-05